STERIS’ (TSE:STE – Free Report) – Raymond James cut their FY2026 earnings per share estimates for shares of STERIS’ in a report issued on Tuesday, October 15th. Raymond James analyst M. Barth now forecasts that the company will post earnings of $0.67 per share for the year, down from their previous forecast of $0.74.
STERIS’ Stock Performance
STERIS’ (TSE:STE – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.12 by C$0.02. The company had revenue of C$231.38 million during the quarter, compared to analyst estimates of C$226.20 million.
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Recommended Stories
- Five stocks we like better than STERIS’
- What is the Shanghai Stock Exchange Composite Index?
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Investing in Construction Stocks
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
